跳至主要内容
临床试验/ACTRN12619000466145
ACTRN12619000466145尚未招募未知

Exploring Treatment Options for Obstructive Sleep Apnoea in People with Psychosis

niversity of Western Australia0 个研究点目标入组 13 人开始时间: 2019年3月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria for participants include:
  • A current diagnosis of psychotic disorder (schizophrenia-spectrum disorder, other psychosis, including anxiety or mood disorders with psychotic features, as diagnosed by their mental health worker)
  • All participants must have a formal diagnosis of OSA confirmed by sleep study (PSG). We will ask them to sign a ‘consent to release’ document, seeking the results of the PSG detailing their sleep disorder diagnosis.
  • Those in the Mandibular Advancement Splint and CPAP will need to have been prescribed those treatments prior to participating in the study (as evidenced in the sleep study results letter)
  • Night Shift participants will need to have a diagnosis of Positional OSA as determined by their PSG data which will be obtained with participant’s consent from the provider of the diagnosis.

排除标准

  • Exclusion criteria include:
  • Inability to provide informed consent
  • Inability to communicate adequately in English
  • Currently experiencing crisis or clinical instability (as assessed by their case manager)
  • Aggression, problematic drug/alcohol usage associated with behavioural or security issues

研究者

发起方
niversity of Western Australia

相似试验